Stockscreener 앱 받기
74.76
0.00%
0.00
시간 외 거래:
73.92
-0.84
-1.12%
전일 마감가:
$74.76
열려 있는:
$79
하루 거래량:
41,387
Relative Volume:
1.08
시가총액:
$244.39M
수익:
$18.47M
순이익/손실:
$-1.05M
주가수익비율:
-212.81
EPS:
-0.3513
순현금흐름:
$-33.87M
1주 성능:
+3.85%
1개월 성능:
-6.55%
6개월 성능:
+34.27%
1년 성능:
+966.48%
1일 변동 폭
$73.01
$79.00
1주일 범위
$71.00
$79.00
52주 변동 폭
$7.0851
$97.97
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Compare SLGL vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
74.76 | 256.42M | 18.47M | -1.05M | -33.87M | -0.3513 |
VRTX
Vertex Pharmaceuticals Inc
|
498.43 | 132.55B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
662.88 | 70.90B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
915.30 | 57.21B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
323.50 | 42.94B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.77 | 40.49B | 742.00K | -1.37B | -1.07B | -7.0731 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-19 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2019-12-31 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-31 | 재확인 | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd 주식(SLGL)의 최신 뉴스
SLGL Technical Analysis & Stock Price Forecast - Intellectia AI
Opaleye boosts Sol-Gel (SLGL) stake with 1,712-share open-market buy - Stock Titan
Sol-Gel Technologies Ltd. Actuals & Estimates (NASDAQ:SLGL) - TradingView
SLGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Price to sales forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Enterprise value to revenue forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Sahm
SLGL Initiates Coverage On Mizuho -- Rating Set to Outperform - GuruFocus
Mizuho Securities Initiates Coverage on Sol-Gel With Outperform Rating, $285 Price Target - Moomoo
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Mizuho initiates Sol Gel stock with Outperform on BCC therapy potential - Investing.com South Africa
Sol-Gel Technologies Initiated at Outperform by Mizuho - Moomoo
ETFs Investing in Sol-Gel Technologies Ltd. Stocks - TradingView
Certain Ordinary Shares of Sol-Gel Technologies Ltd. are subject to a Lock-Up Agreement Ending on 22-JUN-2026. - marketscreener.com
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sol Gel Technologies Ltd (SLGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sol Gel Technologies Ltd (SLGL) Institutional Confidence - TradingKey
Sol Gel Technologies Ltd (SLGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SLGL Q1 2026 Earnings: EPS Surprises to the Upside as Cost Discipline Takes HoldDownward Estimate Revision - newsline.com
Phoenix Financial Ltd. (SLGL) reports 4.99% ownership of Sol‑Gel shares - Stock Titan
Sol-Gel Technologies Ltd. Q1 2026 Earnings: EPS Beat Drives Modest Stock Uptick Despite Continued Pre-Revenue StatusGuidance Update - newsline.com
SLGL Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Stock HigherNext Quarter Guidance - newsline.com
SLGLSol-Gel Technologies Ltd Stock Price and Quote - Finviz
TD Cowen initiates Sol Gel stock with buy on dermatology drug - Investing.com Nigeria
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184 - Moomoo
TD Cowen Initiates Sol-Gel Technologies at Buy - Moomoo
Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative - simplywall.st
Sol-Gel Technologies (SLGL) Reports First Quarter Revenue Decline - GuruFocus
Sol Gel Tech earnings beat by $3.15, revenue fell short of estimates - Investing.com Australia
Sol-Gel Technologies Ltd. (SLGL) reports Q1 loss, lags revenue estimates - MSN
Sol-Gel Technologies 1Q EPS $1.31 >SLGL - Moomoo
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Sol-Gel Technologies Expects Cash Resources to Fund Cash Requirements Into 1Q of 2028 >SLGL - Moomoo
BRIEF-Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand - TradingView
Sol-Gel Technologies (NASDAQ: SLGL) trims Q1 2026 loss and strengthens cash runway - Stock Titan
Sol-Gel wins 2044 patent for Gorlin syndrome gel, raises $33M - Stock Titan
Sol-Gel Q1 2026 earnings: loss narrows as R&D declines - grafa.com
Should I buy SolGel Technologies (SLGL) - Zacks Investment Research
Sol-Gel Technologies (SLGL) Holds Steady Just Below Key Resistance After Modest GainSeasonality Effect - The Legal Advocate
SLGL Q4 2025 Earnings: EPS Misses Estimates as Development-Stage Biotech Reports No RevenueProfit Guidance Range - newsline.com
Sol-Gel Technologies (SLGL) Q4 2025 Earnings: Development-Stage Miss Deepens as Losses Widen; Stock SurgesOperating Income Trends - The Legal Advocate
Opaleye-managed fund buys 1,563 Sol-Gel (SLGL) shares in open market - Stock Titan
SLGL SEC FilingsSol Gel Tech 10-K, 10-Q, 8-K Forms - Stock Titan
Sol Gel Technologies Ltd (SLGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.27%
0.61%
자본화:
|
볼륨(24시간):